Treatment for eradication of Helicobacter pylori infection among chronic hepatitis C patients

Norihiro Furusyo, Ahmed H. Walaa, Kunimitsu Eiraku, Kazuhiro Toyoda, Eiichi Ogawa, Hiroaki Ikezaki, Takeshi Ihara, Takeo Hayashi, Mosaburo Kainuma, Murata Masayuki, Jun Hayashi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background/Aims: Helicobacter pylori infection causes gastritis, peptic ulcers and gastric malignancies, and its eradication has been advocated by many groups. We determined the H. pylori carrier status and eradication rates of patients with chronic hepatitis C virus (HCV) infection. Methods: In total, 76 chronically HCV-infected patients were enrolled for comparison with 228 HCV-noninfected, age- and sex-matched controls. H. pylori infection was confirmed by H. pylori antibody and urea breath testing. Results: The H. pylori infection rate was significantly higher for HCV-infected patients (67 of 76, 88.2%) than for HCV-noninfected controls (158 of 228, 69.3%). Endoscopic findings showed that the rates of gastric ulcers and gastritis were significantly higher for the 67 HCV-infected patients with H. pylori infection (34.3% and 77.6%) than for the 158 HCV-noninfected controls with H. pylori infection (15.2% and 57.6%). Treatment to eradicate H. pylori had a significantly higher success rate for HCV-infected patients (61 of 67, 91.0%) than for HCV-noninfected controls (115 of 158, 72.8%). Conclusions: The markedly high H. pylori eradication rate observed in this study shows that eradication of H. pylori holds promise for the improvement of the long-term health condition of patients with chronic HCV infection.

Original languageEnglish
Pages (from-to)447-453
Number of pages7
JournalGut and Liver
Volume5
Issue number4
DOIs
Publication statusPublished - Dec 1 2011

Fingerprint

Helicobacter Infections
Chronic Hepatitis C
Helicobacter pylori
Hepacivirus
Therapeutics
Gastritis
Virus Diseases
Stomach Ulcer
Peptic Ulcer
Urea
Stomach
Antibodies
Health

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Treatment for eradication of Helicobacter pylori infection among chronic hepatitis C patients. / Furusyo, Norihiro; Walaa, Ahmed H.; Eiraku, Kunimitsu; Toyoda, Kazuhiro; Ogawa, Eiichi; Ikezaki, Hiroaki; Ihara, Takeshi; Hayashi, Takeo; Kainuma, Mosaburo; Masayuki, Murata; Hayashi, Jun.

In: Gut and Liver, Vol. 5, No. 4, 01.12.2011, p. 447-453.

Research output: Contribution to journalArticle

Furusyo, Norihiro ; Walaa, Ahmed H. ; Eiraku, Kunimitsu ; Toyoda, Kazuhiro ; Ogawa, Eiichi ; Ikezaki, Hiroaki ; Ihara, Takeshi ; Hayashi, Takeo ; Kainuma, Mosaburo ; Masayuki, Murata ; Hayashi, Jun. / Treatment for eradication of Helicobacter pylori infection among chronic hepatitis C patients. In: Gut and Liver. 2011 ; Vol. 5, No. 4. pp. 447-453.
@article{dd147a1ce14542f7a546194ab8071231,
title = "Treatment for eradication of Helicobacter pylori infection among chronic hepatitis C patients",
abstract = "Background/Aims: Helicobacter pylori infection causes gastritis, peptic ulcers and gastric malignancies, and its eradication has been advocated by many groups. We determined the H. pylori carrier status and eradication rates of patients with chronic hepatitis C virus (HCV) infection. Methods: In total, 76 chronically HCV-infected patients were enrolled for comparison with 228 HCV-noninfected, age- and sex-matched controls. H. pylori infection was confirmed by H. pylori antibody and urea breath testing. Results: The H. pylori infection rate was significantly higher for HCV-infected patients (67 of 76, 88.2{\%}) than for HCV-noninfected controls (158 of 228, 69.3{\%}). Endoscopic findings showed that the rates of gastric ulcers and gastritis were significantly higher for the 67 HCV-infected patients with H. pylori infection (34.3{\%} and 77.6{\%}) than for the 158 HCV-noninfected controls with H. pylori infection (15.2{\%} and 57.6{\%}). Treatment to eradicate H. pylori had a significantly higher success rate for HCV-infected patients (61 of 67, 91.0{\%}) than for HCV-noninfected controls (115 of 158, 72.8{\%}). Conclusions: The markedly high H. pylori eradication rate observed in this study shows that eradication of H. pylori holds promise for the improvement of the long-term health condition of patients with chronic HCV infection.",
author = "Norihiro Furusyo and Walaa, {Ahmed H.} and Kunimitsu Eiraku and Kazuhiro Toyoda and Eiichi Ogawa and Hiroaki Ikezaki and Takeshi Ihara and Takeo Hayashi and Mosaburo Kainuma and Murata Masayuki and Jun Hayashi",
year = "2011",
month = "12",
day = "1",
doi = "10.5009/gnl.2011.5.4.447",
language = "English",
volume = "5",
pages = "447--453",
journal = "Gut and Liver",
issn = "1976-2283",
publisher = "Joe Bok Chung",
number = "4",

}

TY - JOUR

T1 - Treatment for eradication of Helicobacter pylori infection among chronic hepatitis C patients

AU - Furusyo, Norihiro

AU - Walaa, Ahmed H.

AU - Eiraku, Kunimitsu

AU - Toyoda, Kazuhiro

AU - Ogawa, Eiichi

AU - Ikezaki, Hiroaki

AU - Ihara, Takeshi

AU - Hayashi, Takeo

AU - Kainuma, Mosaburo

AU - Masayuki, Murata

AU - Hayashi, Jun

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Background/Aims: Helicobacter pylori infection causes gastritis, peptic ulcers and gastric malignancies, and its eradication has been advocated by many groups. We determined the H. pylori carrier status and eradication rates of patients with chronic hepatitis C virus (HCV) infection. Methods: In total, 76 chronically HCV-infected patients were enrolled for comparison with 228 HCV-noninfected, age- and sex-matched controls. H. pylori infection was confirmed by H. pylori antibody and urea breath testing. Results: The H. pylori infection rate was significantly higher for HCV-infected patients (67 of 76, 88.2%) than for HCV-noninfected controls (158 of 228, 69.3%). Endoscopic findings showed that the rates of gastric ulcers and gastritis were significantly higher for the 67 HCV-infected patients with H. pylori infection (34.3% and 77.6%) than for the 158 HCV-noninfected controls with H. pylori infection (15.2% and 57.6%). Treatment to eradicate H. pylori had a significantly higher success rate for HCV-infected patients (61 of 67, 91.0%) than for HCV-noninfected controls (115 of 158, 72.8%). Conclusions: The markedly high H. pylori eradication rate observed in this study shows that eradication of H. pylori holds promise for the improvement of the long-term health condition of patients with chronic HCV infection.

AB - Background/Aims: Helicobacter pylori infection causes gastritis, peptic ulcers and gastric malignancies, and its eradication has been advocated by many groups. We determined the H. pylori carrier status and eradication rates of patients with chronic hepatitis C virus (HCV) infection. Methods: In total, 76 chronically HCV-infected patients were enrolled for comparison with 228 HCV-noninfected, age- and sex-matched controls. H. pylori infection was confirmed by H. pylori antibody and urea breath testing. Results: The H. pylori infection rate was significantly higher for HCV-infected patients (67 of 76, 88.2%) than for HCV-noninfected controls (158 of 228, 69.3%). Endoscopic findings showed that the rates of gastric ulcers and gastritis were significantly higher for the 67 HCV-infected patients with H. pylori infection (34.3% and 77.6%) than for the 158 HCV-noninfected controls with H. pylori infection (15.2% and 57.6%). Treatment to eradicate H. pylori had a significantly higher success rate for HCV-infected patients (61 of 67, 91.0%) than for HCV-noninfected controls (115 of 158, 72.8%). Conclusions: The markedly high H. pylori eradication rate observed in this study shows that eradication of H. pylori holds promise for the improvement of the long-term health condition of patients with chronic HCV infection.

UR - http://www.scopus.com/inward/record.url?scp=81855176460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81855176460&partnerID=8YFLogxK

U2 - 10.5009/gnl.2011.5.4.447

DO - 10.5009/gnl.2011.5.4.447

M3 - Article

C2 - 22195242

AN - SCOPUS:81855176460

VL - 5

SP - 447

EP - 453

JO - Gut and Liver

JF - Gut and Liver

SN - 1976-2283

IS - 4

ER -